To determine whether these hormones participate in the insulin‐sensitizing action of SSTR5 inhibition, we evaluated the effects of alogliptin, a dipeptidyl peptidase 4 (DPP4) inhibitor that increases plasma GLP‐1 and insulin levels, on insulin resistance in KK‐Ay mice. Here, DPP4 is linked to Insulin resistance.